PRECISEU Matchmaking Platform

20 Oct 2025 – 31 Jan 2026 | Barcelona, Spain

Register
Register
Register

Business OpportunityUpdated on 16 December 2025

DIGITAL HEALTH CARE ASSISTANCE CHRONIC DISEASES

Company Management WIN5 at WIN5

Stuttgart, Germany

About

Our digital health care assistant is a modular, patient-centered solution designed to support the practical implementation of Disease Management Programs (DMPs) for chronic conditions such as Asthma, Diabetes, Breast Cancer, Cardiovascular Disease, COPD, Chronic Back Pain, Osteoporosis, Rheumatoid Arthritis, and Prostate Cancer. Our digital assistant transforms Disease Management Programs into daily practice. From asthma to oncology, it empowers patients and care teams with personalized tools, AI-driven insights, and seamless coordination.

The assistant combines evidence-based guidelines with intuitive digital tools to empower patients and healthcare providers alike. Key features include:

  • 📱 Personalized Patient Interface: Tailored dashboards for symptom tracking, medication adherence, and lifestyle goals.

  • 🧠 AI-Driven Decision Support: Real-time alerts and recommendations based on DMP protocols and patient-reported outcomes.

  • 🤝 Integrated Care Coordination: Secure communication between patients, GPs, specialists, and care teams.

  • 📊 Data-Driven Insights: Aggregated health data visualizations to support shared decision-making and early intervention.

  • 🌍 Multilingual & Accessible: Designed for diverse populations, with support for German and English, and inclusive UX.

Ready to scale.

Innovation: Medical frameworks, guidelines, and reimbursement structures are already in place. What’s missing is a compatible digital solution. Our assistant fills this gap: the first scalable tool for DMP education in daily practice. TRL 7 – prototype ready, scaling in progress.The framework conditions for Disease Management Programs (DMPs) are already established for digital implementation by the Federal Joint Committee (G-BA)

Impact: With over 10 million potential patients in Germany alone and similar numbers across Europe, this solution offers massive potential for personalized chronic care. It empowers practices, boosts adherence, and reduces system costs.

Relevance: Currently, only around 35% of asthma patients in Baden-Württemberg receive structured education. The target is at least 80%. For asthma alone, this represents a potential of approximately 4 million patients. Similar gaps exist across other indications: for example, COPD education reaches only 30% of patients, breast cancer just 15%, and so on.

Challenge: The medical knowledge base is well established, and the clinical parameters for each diagnosis are clearly defined. The main challenge lies in developing a compatible digital physician assistant that can operationalize these Disease Management Programs (DMPs). A second challenge is the implementation dynamic within specialist practices, which requires workflow restructuring and learning. However, the scientific mandate is clear, reimbursement is secured through extra-budgetary mechanisms, and even the “Digital DMPs” (D-DMPs) have already been approved by the Federal Joint Committee (G-BA). With support from health insurers, we can accelerate adoption and scale implementation.

Goal: Development of a digital health care assistant powered by your technical expertise.

Stage

  • TRL 7

Topic

  • Diseases of the ear
  • Endocrine/nutritional/metabolic diseases
  • External causes of morbidity, mortality
  • Mental and behavioural disorders / psychiatry /psychology
  • Musculoskeletal system, connective tissue
  • Diseases of the nervous system / neurology
  • Respiratory
  • Rare diseases

Sector

  • Health data
  • Rare diseases

Type

  • Co-development
  • Regulatory expert
  • Consortium partners

Organisation

WIN5

Consultancy

Stuttgart, Germany

Similar opportunities

  • Business Opportunity

    vitalera: Making Hospital-at-Home a Reality with AI

    • AI
    • TRL 8
    • Oncology
    • Physiology
    • Pediatrics
    • Licensing
    • Respiratory
    • Health data
    • Rare diseases
    • Rare diseases
    • Bioinformatics
    • Cardiovascular
    • Co-development
    • Digestive system
    • Consortium partners
    • Regenerative medicine
    • Research collaboration
    • External causes of morbidity, mortality
    • Injury, poisoning, other external causes
    • Pregnancy, childbirth and the puerperium
    • Musculoskeletal system, connective tissue
    • Other symptoms, deviant clinical findings
    • Diseases of the blood and immune disorders
    • Diseases of the nervous system / neurology
    • Mental and behavioural disorders / psychiatry /psychology

    Nuria Pastor

    General Manager at vitalera

    Barcelona, Spain

  • Business Opportunity

    AI-powered Healthcare with therapeutic red blood cells

    • AI
    • TRL 6
    • ATMPs
    • Health data
    • Diagnostics
    • Rare diseases
    • Rare diseases
    • Co-development
    • Clinical validation
    • Regenerative medicine
    • Endocrine/nutritional/metabolic diseases
    • Diseases of the nervous system / neurology
    • Mental and behavioural disorders / psychiatry /psychology

    Denis Demarais

    Founder and CEO at Rius Medical

    Waldachtal, Germany

  • Business Opportunity

    NextPIDCAP: Implementing a standardized clinical decision support tool to enhance early identification of primary immunodeficiencies

    • TRL 6
    • TRL 7
    • TRL 8
    • Health data
    • Rare diseases
    • Research collaboration
    • Congenital or chromosomal abnormalities
    • Diseases of the blood and immune disorders

    Jacques Riviere

    Pediatric immunologist, researcher at Vall d'Hebron Research Institute (VHIR)

    Barcelona, Spain